NIZZARDO, MONICA
NIZZARDO, MONICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells
2011 S. Corti, F. Magri, M. Nizzardo, C. Simone, M. Falcone, S. Salani, C. Donadoni, M. Nardini, G. Riboldi, G. Menozzi, C. Bonaglia, F. Rizzo, N. Bresolin, G. Comi
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development
2011 G. Riboldi, M. Nizzardo, C. Simone, M. Falcone, N. Bresolin, G. Comi, S. Corti
Analisi molecolare del gene GAA e caratterizzazione di due nuove mutazioni di splicing in pazienti con deficit di maltasi acida.
2008 D. Ronchi, G. Remiche, A. Bordoni, E. Fassone, C. Montrasio, F. Magri, G.P. Comi, M. Nizzardo
Animal Models of CMT2A: State-of-art and Therapeutic Implications
2020 R. De Gioia, G. Citterio, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, F. Rizzo
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases
2014 G. Riboldi, C. Zanetta, M. Ranieri, M. Nizzardo, C. Simone, F. Magri, N. Bresolin, G.P. Comi, S. Corti
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms
2010 S. Corti, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, C. Simone, M. Falcone, G. Riboldi, N. Bresolin, G.P. Comi
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms
2010 M. Nizzardo, M. Nardini, D. Ronchi, S. Salani, C. Simone, M. Falcone, C. Donadoni, G.P. Comi, S.P. Corti
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms
2011 M. Nizzardo, M. Nardini, D. Ronchi, S. Salani, C. Donadoni, F. Fortunato, G. Colciago, M. Falcone, C. Simone, G. Riboldi, A. Govoni, N. Bresolin, G.P. Comi, S. Corti, S. Bhatia
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms
2011 M. Nizzardo, M. Nardini, D. Ronchi, S. Salani, C. Donadoni, F. Fortunato, G. Colciago, M. Falcone, C. Simone, G. Riboldi, A. Govoni, N. Bresolin, G.P. Comi, S. Corti
Ceftriaxone treatment improves phenotype in a murine model of spinal muscular
2008 M. Nardini, M. Nizzardo, C. Donadoni, F. Fortunato, N. Bresolin, G.P. Comi, S. Corti
Cell Penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2021 M. Bersani, M. Rizzuti, E. Pagliari, M. Garbellini, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2014 F. Rizzo, G. Riboldi, S. Salani, M. Nizzardo, C. Simone, S. Corti, E. Hedlund
Cellule staminali neuronali derivate da staminali embrionali murine migliorano il fenotipo di un modello murino di Atrofia Spinale Muscolare (SMA)”.
2008 M. Nizzardo, S. Corti, M. Nardini, C. Donadoni, S. Salani, F. Locatelli, D. Papadimitriou, G.P. Comi
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti
CPPs-conjugated antisense nucleotides : a new therapeutic strategy for Spinal Muscular Atrophy symptomatic patients
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
CPPs-conjugated antisense nucleotides : a new therapeutic strategy for Spinal Muscular Atrophy symptomatic patients
2019 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, G. Comi, S. Corti, M. Nizzardo
CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1
2019 G. Forotti, M. Nizzardo, M. Bucchia, A. Ramirez, E. Trombetta, S. Gatti, N. Bresolin, G.P. Comi, S. Corti
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
2020 M.G.L. Perego, N. Galli, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons
2011 M. Nizzardo, C. Simone, M. Falcone, C. Donadoni, M. Nardini, S. Salani, F. Magri, G. Riboldi, R. Del Bo, S. Corti, G. Comi